Promoter methylation analysis of WNT/β-catenin signaling pathway regulators to detect adenocarcinoma or its precursor lesion of the cervix

Gynecologic Oncology

Volumn 123, Issue 1, 2011, Pages 116-122

  Van Der Meide, W F ^a   Snellenberg, S ^a   Meijer, C J L M ^a   Baalbergen, A ^c   Helmerhorst, T J M ^b   Van Der Sluis, W B ^a   Snijders, P J F ^a   Steenbergen, R D M ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

^c REINIER DE GRAAF HOSPITAL   (Netherlands)

Author keywords

Adenocarcinoma; Cervical cancer; DNA methylation; Early detection; WNT signaling

Indexed keywords

APC PROTEIN; AXIN2 PROTEIN; BETA CATENIN; DICKKOPF 1 PROTEIN; DICKKOPF 3 PROTEIN; REGULATOR PROTEIN; SECRETED FRIZZLED RELATED PROTEIN 2; SECRETED FRIZZLED RELATED PROTEIN 4; SECRETED FRIZZLED RELATED PROTEIN 5; TRANSCRIPTION FACTOR SOX17; UNCLASSIFIED DRUG; WNT INHIBITORY FACTOR 1; WNT PROTEIN; WNT5A PROTEIN;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN METHYLATION; QUANTITATIVE ANALYSIS; SIGNAL TRANSDUCTION; UTERINE CERVIX ADENOCARCINOMA; UTERINE CERVIX CARCINOMA; UTERINE CERVIX CARCINOMA IN SITU; WART VIRUS;

ADENOCARCINOMA; ADULT; BETA CATENIN; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; CERVICAL INTRAEPITHELIAL NEOPLASIA; DNA METHYLATION; FEMALE; HUMANS; MIDDLE AGED; PROMOTER REGIONS, GENETIC; SIGNAL TRANSDUCTION; UTERINE CERVICAL NEOPLASMS; WNT PROTEINS; YOUNG ADULT;

EID: 80052593788     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2011.06.015     Document Type: Article

References (53)

1. S. Bulk, O. Visser, L. Rozendaal, R.H. Verheijen, and C.J. Meijer Cervical cancer in the Netherlands 1989-1998: decrease of squamous cell carcinoma in older women, increase of adenocarcinoma in younger women Int J Cancer 113 2005 1005 1009 (Pubitemid 40096882)
2. H.O. Smith, M.F. Tiffany, C.R. Qualls, and C.R. Key The rising incidence of adenocarcinoma relative to squamous cell carcinoma of the uterine cervix in the United States-a 24-year population-based study Gynecol Oncol 78 2000 97 105 (Pubitemid 30650338)
3. A.P. Vizcaino, V. Moreno, F.X. Bosch, N. Munoz, X.M. Barros-Dios, and J. Borras International trends in incidence of cervical cancer: II. Squamous-cell carcinoma Int J Cancer 86 2000 429 435 (Pubitemid 30187507)
4. A.P. Vizcaino, V. Moreno, F.X. Bosch, N. Munoz, X.M. Barros-Dios, and D.M. Parkin International trends in the incidence of cervical cancer: I. Adenocarcinoma and adenosquamous cell carcinomas Int J Cancer 75 1998 536 545 (Pubitemid 28094098)
5. P. Sasieni, A. Castanon, and J. Cuzick Screening and adenocarcinoma of the cervix Int J Cancer 125 2009 525 529
6. M. Zappa, C.B. Visioli, S. Ciatto, A. Iossa, E. Paci, and P. Sasieni Lower protection of cytological screening for adenocarcinomas and shorter protection for younger women: the results of a case-control study in Florence Br J Cancer 90 2004 1784 1786 (Pubitemid 38725653)
7. S. Bulk, J. Berkhof, N.W. Bulkmans, G.D. Zielinski, L. Rozendaal, and F.J. van Kemenade Preferential risk of HPV16 for squamous cell carcinoma and of HPV18 for adenocarcinoma of the cervix compared to women with normal cytology in The Netherlands Br J Cancer 94 2006 171 175 (Pubitemid 43088560)
8. X. Castellsague, M. Diaz, S. de Sanjose, N. Munoz, R. Herrero, and S. Franceschi Worldwide human papillomavirus etiology of cervical adenocarcinoma and its cofactors: implications for screening and prevention J Natl Cancer Inst 98 2006 303 315 (Pubitemid 43338210)
9. J. Berkhof, N.W. Bulkmans, M.C. Bleeker, S. Bulk, P.J. Snijders, and F.J. Voorhorst Human papillomavirus type-specific 18-month risk of high-grade cervical intraepithelial neoplasia in women with a normal or borderline/mildly dyskaryotic smear Cancer Epidemiol Biomarkers Prev 15 2006 1268 1273 (Pubitemid 44125280)
10. W. Kinney, B. Fetterman, J.T. Cox, T. Lorey, T. Flanagan, and P.E. Castle Characteristics of 44 cervical cancers diagnosed following Pap-negative, high risk HPV-positive screening in routine clinical practice Gynecol Oncol 121 2011 309 313
11. S.A. Qureshi, M.U. Bashir, and A. Yaqinuddin Utility of DNA methylation markers for diagnosing cancer Int J Surg 8 2010 194 198
12. R.M. Overmeer, F.E. Henken, M. Bierkens, S.M. Wilting, I. Timmerman, and C.J. Meijer Repression of MAL tumour suppressor activity by promoter methylation during cervical carcinogenesis J Pathol 219 2009 327 336
13. R.M. Overmeer, J.A. Louwers, C.J. Meijer, F.J. van Kemenade, A.T. Hesselink, and N.F. Daalmeijer Combined CADM1 and MAL promoter methylation analysis to detect (pre-)malignant cervical lesions in high-risk HPV-positive women Int J Cancer 2010 (Electronic publication ahead of print)
14. F.E. Henken, S.M. Wilting, R.M. Overmeer, J.G. van Rietschoten, A.O. Nygren, and A. Errami Sequential gene promoter methylation during HPV-induced cervical carcinogenesis Br J Cancer 97 2007 1457 1464 (Pubitemid 350114795)
15. S. Kang, J.W. Kim, G.H. Kang, S. Lee, N.H. Park, and Y.S. Song Comparison of DNA hypermethylation patterns in different types of uterine cancer: cervical squamous cell carcinoma, cervical adenocarcinoma and endometrial adenocarcinoma Int J Cancer 118 2006 2168 2171
16. S.M. Wilting, J. de Wilde, C.J. Meijer, J. Berkhof, Y. Yi, and W.N. van Wieringen Integrated genomic and transcriptional profiling identifies chromosomal loci with altered gene expression in cervical cancer Genes Chromosomes Cancer 47 2008 890 905
17. S. Mohinta, H. Wu, P. Chaurasia, and K. Watabe Wnt pathway and breast cancer Front Biosci 12 2007 4020 4033
18. J.J. Smith, N.G. Deane, P. Dhawan, and R.D. Beauchamp Regulation of metastasis in colorectal adenocarcinoma: a collision between development and tumor biology Surgery 144 2008 353 366
19. G. Zeng, M. Germinaro, A. Micsenyi, N.K. Monga, A. Bell, and A. Sood Aberrant Wnt/beta-catenin signaling in pancreatic adenocarcinoma Neoplasia 8 2006 279 289
20. A. Uren, S. Fallen, H. Yuan, A. Usubutun, T. Kucukali, and R. Schlegel Activation of the canonical Wnt pathway during genital keratinocyte transformation: a model for cervical cancer progression Cancer Res 65 2005 6199 6206 (Pubitemid 40994405)
21. M.T. Chung, H.C. Lai, H.K. Sytwu, M.D. Yan, Y.L. Shih, and C.C. Chang SFRP1 and SFRP2 suppress the transformation and invasion abilities of cervical cancer cells through Wnt signal pathway Gynecol Oncol 112 2009 646 653
22. A.L. Pereira-Suarez, M.A. Meraz, M. Lizano, C. Estrada-Chavez, F. Hernandez, and P. Olivera Frequent alterations of the beta-catenin protein in cancer of the uterine cervix Tumour Biol 23 2002 45 53 (Pubitemid 34225021)
23. A. Shinohara, Y. Yokoyama, X. Wan, Y. Takahashi, Y. Mori, and T. Takami Cytoplasmic/nuclear expression without mutation of exon 3 of the beta-catenin gene is frequent in the development of the neoplasm of the uterine cervix Gynecol Oncol 82 2001 450 455 (Pubitemid 32826443)
24. H. Lichtig, D.A. Gilboa, A. Jackman, P. Gonen, Y. Levav-Cohen, and Y. Haupt HPV16 E6 augments Wnt signaling in an E6AP-dependent manner Virology 396 2010 47 58
25. T. Rampias, E. Boutati, E. Pectasides, C. Sasaki, P. Kountourakis, and P. Weinberger Activation of Wnt signaling pathway by human papillomavirus E6 and E7 oncogenes in HPV16-positive oropharyngeal squamous carcinoma cells Mol Cancer Res 8 2010 433 443
26. E.J. Lee, M. Jo, S.B. Rho, K. Park, Y.N. Yoo, and J. Park Dkk3, downregulated in cervical cancer, functions as a negative regulator of beta-catenin Int J Cancer 124 2009 287 297
27. S.M. Dong, H.S. Kim, S.H. Rha, and D. Sidransky Promoter hypermethylation of multiple genes in carcinoma of the uterine cervix Clin Cancer Res 7 2001 1982 1986 (Pubitemid 32994835)
28. Y.W. Lin, M.T. Chung, H.C. Lai, M. De Yan, Y.L. Shih, and C.C. Chang Methylation analysis of SFRP genes family in cervical adenocarcinoma J Cancer Res Clin Oncol 135 2009 1665 1674
29. M.T. Chung, H.K. Sytwu, M.D. Yan, Y.L. Shih, C.C. Chang, and M.H. Yu Promoter methylation of SFRPs gene family in cervical cancer Gynecol Oncol 112 2009 301 306
30. R.D. Steenbergen, D. Kramer, B.J. Braakhuis, P.L. Stern, R.H. Verheijen, and C.J. Meijer TSLC1 gene silencing in cervical cancer cell lines and cervical neoplasia J Natl Cancer Inst 96 2004 294 305 (Pubitemid 38256274)
31. N.W. Bulkmans, J. Berkhof, L. Rozendaal, F.J. van Kemenade, A.J. Boeke, and S. Bulk Human papillomavirus DNA testing for the detection of cervical intraepithelial neoplasia grade 3 and cancer: 5-year follow-up of a randomised controlled implementation trial Lancet 370 2007 1764 1772 (Pubitemid 350137476)
32. M.V. Jacobs, P.J. Snijders, A.J. van den Brule, T.J. Helmerhorst, C.J. Meijer, and J.M. Walboomers A general primer GP5+/GP6(+)-mediated PCR-enzyme immunoassay method for rapid detection of 14 high-risk and 6 low-risk human papillomavirus genotypes in cervical scrapings J Clin Microbiol 35 1997 791 795 (Pubitemid 27083888)
33. A.J. van den Brule, R. Pol, N. Fransen-Daalmeijer, L.M. Schouls, C.J. Meijer, and P.J. Snijders GP5+/6+ PCR followed by reverse line blot analysis enables rapid and high-throughput identification of human papillomavirus genotypes J Clin Microbiol 40 2002 779 787 (Pubitemid 34208623)
34. S.V. Harden, Z. Guo, J.I. Epstein, and D. Sidransky Quantitative GSTP1 methylation clearly distinguishes benign prostatic tissue and limited prostate adenocarcinoma J Urol 169 2003 1138 1142 (Pubitemid 36188189)
35. R.M. Overmeer, F.E. Henken, P.J. Snijders, D. Claassen-Kramer, J. Berkhof, and T.J. Helmerhorst Association between dense CADM1 promoter methylation and reduced protein expression in high-grade CIN and cervical SCC J Pathol 215 2008 388 397
36. M.W. Pfaffl A new mathematical model for relative quantification in real-time RT-PCR Nucleic Acids Res 29 2001 e45
37. Y. Ying, and Q. Tao Epigenetic disruption of the WNT/beta-catenin signaling pathway in human cancers Epigenetics 4 2009 307 312
38. F. Abarzua, M. Sakaguchi, M. Takaishi, Y. Nasu, K. Kurose, and S. Ebara Adenovirus-mediated overexpression of REIC/Dkk-3 selectively induces apoptosis in human prostate cancer cells through activation of c-Jun-NH2-kinase Cancer Res 65 2005 9617 9622 (Pubitemid 41541434)
39. S.Y. Hsieh, P.S. Hsieh, C.T. Chiu, and W.Y. Chen Dickkopf-3/REIC functions as a suppressor gene of tumor growth Oncogene 23 2004 9183 9189
40. S. Kuphal, S. Lodermeyer, F. Bataille, M. Schuierer, B.H. Hoang, and A.K. Bosserhoff Expression of Dickkopf genes is strongly reduced in malignant melanoma Oncogene 25 2006 5027 5036
41. P. Parrella, A. la Torre, M. Copetti, V.M. Valori, R. Barbano, and A. Notarangelo High specificity of quantitative methylation-specific PCR analysis for MGMT promoter hypermethylation detection in gliomas J Biomed Biotechnol 2009 2009 531692
42. H. Enokida, H. Shiina, S. Urakami, M. Igawa, T. Ogishima, and D. Pookot Ethnic group-related differences in CpG hypermethylation of the GSTP1 gene promoter among African-American, Caucasian and Asian patients with prostate cancer Int J Cancer 116 2005 174 181 (Pubitemid 40967252)
43. P.M. Das, K. Ramachandran, J. Vanwert, L. Ferdinand, G. Gopisetty, and I.M. Reis Methylation mediated silencing of TMS1/ASC gene in prostate cancer Mol Cancer 5 2006 28
44. Y.C. Du, H. Oshima, K. Oguma, T. Kitamura, H. Itadani, and T. Fujimura Induction and down-regulation of Sox17 and its possible roles during the course of gastrointestinal tumorigenesis Gastroenterology 137 2009 1346 1357
45. D.Y. Fu, Z.M. Wang, C. Li, B.L. Wang, Z.Z. Shen, and W. Huang Sox17, the canonical Wnt antagonist, is epigenetically inactivated by promoter methylation in human breast cancer Breast Cancer Res Treat 119 2010 601 612
46. W. Zhang, S.C. Glockner, M. Guo, E.O. Machida, D.H. Wang, and H. Easwaran Epigenetic inactivation of the canonical Wnt antagonist SRY-box containing gene 17 in colorectal cancer Cancer Res 68 2008 2764 2772 (Pubitemid 351556274)
47. L. Ai, Q. Tao, S. Zhong, C.R. Fields, W.J. Kim, and M.W. Lee Inactivation of Wnt inhibitory factor-1 (WIF1) expression by epigenetic silencing is a common event in breast cancer Carcinogenesis 27 2006 1341 1348 (Pubitemid 43985409)
48. Y. Deng, B. Yu, Q. Cheng, J. Jin, H. You, and R. Ke Epigenetic silencing of WIF-1 in hepatocellular carcinomas J Cancer Res Clin Oncol 136 2010 1161 1167
49. N.W. Bulkmans, L. Rozendaal, P.J. Snijders, F.J. Voorhorst, A.J. Boeke, and G.R. Zandwijken POBASCAM, a population-based randomized controlled trial for implementation of high-risk HPV testing in cervical screening: design, methods and baseline data of 44,102 women Int J Cancer 110 2004 94 101 (Pubitemid 38507208)
50. D.C. Rijkaart, J. Berkhof, F.J. van Kemenade, L. Rozendaal, R.H. Verheijen, and S. Bulk Comparison of HPV and cytology triage algorithms for women with borderline or mild dyskaryosis in population-based cervical screening (VUSA-screen study) Int J Cancer 126 2010 2175 2181
51. K. Elfgren, E. Rylander, T. Radberg, B. Strander, A. Strand, and K. Paajanen Colposcopic and histopathologic evaluation of women participating in population-based screening for human papillomavirus deoxyribonucleic acid persistence Am J Obstet Gynecol 193 2005 650 657 (Pubitemid 41261457)
52. H.C. Kitchener, M. Almonte, P. Wheeler, M. Desai, C. Gilham, and A. Bailey HPV testing in routine cervical screening: cross sectional data from the ARTISTIC trial Br J Cancer 95 2006 56 61 (Pubitemid 43980554)
53. A.T. Hesselink, D.A. Heideman, R.D. Steenbergen, V.M. Coupe, R.M. Overmeer, and D. Rijkaart Combined promoter methylation analysis of CADM1 and MAL: an objective triage tool for high-risk human papillomavirus DNA-positive women Clin Cancer Res 17 2011 2459 2465